Protagonist Therapeutics PTGX
NASDAQ PTGX
$139.10 -0.09 (-0.06%)
As of: Oct 2, 2026 · 1:51 PM EDT

Protagonist Therapeutics (PTGX) Long-Term Debt Issuances (2019 - 2023)

Updated

Protagonist Therapeutics' Long-Term Debt Issuances came in at $24.3 million for FY2023, up 67.0% from $14.55 million in FY2022.

Analysis

Protagonist Therapeutics (PTGX) Long-Term Debt Issuances (2019 - 2023) Analysis & Trends

Going back to FY2018, Protagonist Therapeutics' Long-Term Debt Issuances data covers 5 years.

  • Long-Term Debt Issuances carries a five-year compound annual growth rate of 74.4% (FY2018 to FY2023).
  • The FY2023 figure represents the highest annual Long-Term Debt Issuances since FY2020.
  • Per Business Quant, earlier years put Long-Term Debt Issuances at $14.55 million in FY2022, $42.06 million in FY2020 (+21.9%) and $34.49 million in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 1.98 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Protagonist Therapeutics 9.11 Bn 9.11 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 24.30 Mn
Mar 31, 2022 14.55 Mn
Dec 31, 2020 18.84 Mn
Sep 30, 2020 6.39 Mn
Sep 30, 2019 23.95 Mn
API Access

Protagonist Therapeutics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=PTGX&period=max&api_key=YOUR_API_KEY